Global & Public Health (all articles)
[News release – not published yet] New guidelines from WHO recommend a simpler, safer treatment for cryptococcal disease in people living with HIV.
21 Apr, 2022 | 10:28h | UTCRelated Study: Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis – New England Journal of Medicine (link to abstract – $ for full-text)
Cohort study: COVID-19 infection granted patients strong and long-lasting protection from reinfection.
21 Apr, 2022 | 10:20h | UTCNews Release: COVID-19 infection granted patients strong and long-lasting protection from reinfection – Providence Health & Services
Original Study: Rates of COVID-19 Among Unvaccinated Adults With Prior COVID-19 – JAMA Network Open
Commentary: COVID-19 infection may offer similar immunity as vaccination – CIDRAP
Commentary on Twitter
This US cohort study found that unvaccinated individuals with prior symptomatic #COVID19 had 85% lower risk against recurrent COVID-19 compared to unvaccinated individuals without prior infection, for up to 9 months, through November, 2021. https://t.co/1qHCFmGqXG
— JAMA Network Open (@JAMANetworkOpen) April 20, 2022
Covid hasn’t given up all its secrets. Here are 6 mysteries experts hope to unravel.
20 Apr, 2022 | 09:57h | UTCCovid hasn’t given up all its secrets. Here are 6 mysteries experts hope to unravel – STAT
Cohort Study: Rates and causes of mortality among children and young people with and without intellectual disabilities in Scotland.
20 Apr, 2022 | 09:22h | UTC
Commentary on Twitter
Very sobering study based on Scottish data. Children and young people with intellectual disability are at far higher risk of death and are more likely to have an avoidable death – one amenable to timely, effective care. https://t.co/xuxYjVrRd8
— Mary Dixon-Woods (@MaryDixonWoods) April 16, 2022
National, regional, and global estimates of anemia by severity in women and children for 2000–19.
20 Apr, 2022 | 09:25h | UTCInvited Commentary: Sustainable Development Goals for anaemia: 20 years later, where are we now? – The Lancet Global Health
Omicron-specific Sinopharm, Sinovac COVID vaccine candidates cleared for clinical trial.
19 Apr, 2022 | 02:25h | UTCOmicron-specific Sinopharm, Sinovac COVID vaccine candidates cleared for clinical trial – Reuters
Commentary on Twitter
In China, #Omicron-specific vaccines are slated for clinical trials. The vaccine candidates were developed by a Sinopharm subsidiary and Sinovac Biotech. The vaccines are headed to clinical trials in Hong Kong https://t.co/6Y9LsGCKbn
— delthia ricks 🔬 (@DelthiaRicks) April 17, 2022
M-A: Global prevalence of post COVID-19 condition or long COVID.
19 Apr, 2022 | 02:18h | UTCCommentary: Global data reveal half may have long COVID 4 months on – CIDRAP
Commentary on Twitter (thread – click for more)
🚨The so far largest meta-analysis of more than 1.5 million infected individuals puts the global prevalence of #LongCovid at 43%. Some additional key findings. 🧵https://t.co/XGu23MV3Ra
1/— Jonas R. Kunst (@kunstjonas.bsky.social) (@KunstJonas) April 17, 2022
A systematic review of COVID-19 vaccine efficacy and effectiveness against SARS-CoV-2 infection and disease.
19 Apr, 2022 | 02:14h | UTC
Commentary on Twitter
🆕💥💥Systematic Review collected efficacy & effectiveness values by vaccine platform, disease outcome, number of doses, & SARS-CoV-2 variants
The spread of the Omicron beginning late 2021 is at least partially driven by reductions in vaccine effectiveness https://t.co/A7hDTQGY4K— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) April 18, 2022
Review: Covid-19: virology, variants, and vaccines.
18 Apr, 2022 | 10:50h | UTCCovid-19: virology, variants, and vaccines – BMJ Medicine
Commentary on Twitter
🆕 New review on #COVID: virology, variants and vaccines by Megan Young, Harry Crook, Janet Scott and Paul Edison from @ImperialMed
➡️ Read it now! https://t.co/hYrCQYVvNr#BMJMedicine #MedTwitter pic.twitter.com/aGA0DsX38K— BMJMedicine (@BMJMedicine) April 14, 2022
Household transmission of SARS-CoV-2 from unvaccinated asymptomatic and symptomatic household members with confirmed SARS-CoV-2 infection: an antibody-surveillance study.
18 Apr, 2022 | 10:52h | UTCCommentary: COVID-19 household transmission is high, with children being a significant source of spread: study – CHEO
Commentary on Twitter (thread – click for more)
This new study on household transmission of #COVID19 from Canada is pretty interesting
-Children made up less than half index cases
-Adults odds of transmitting more than double vs children
-Mask use in household didn't reduce transmission— Alasdair Munro (@apsmunro) April 14, 2022
Analysis: Changing the assortment of available food and drink for leaner, greener diets.
18 Apr, 2022 | 10:39h | UTCChanging the assortment of available food and drink for leaner, greener diets – The BMJ
News Release: Changing products on offer in shops and restaurants can lead to leaner, greener diets – BMJ
Incidence of electric scooter–associated injuries in Finland from 2019 to 2021.
18 Apr, 2022 | 09:54h | UTCIncidence of Electric Scooter–Associated Injuries in Finland From 2019 to 2021 – JAMA Network Open
Commentary on Twitter
This cross-sectional study found that actual incidence of any injury and major trauma was 18/100k and 5.9/100k trips taken with rental e-scooters in Finland. https://t.co/ZKz1j219vQ
— JAMA Network Open (@JAMANetworkOpen) April 14, 2022
Systematic Review: The effect of conditional cash transfers on the control of neglected tropical disease.
18 Apr, 2022 | 09:38h | UTCInvited Commentary: The potential of conditional cash transfers for the control of neglected tropical diseases – The Lancet Global Health
Commentary from the author on Twitter (thread – click for more)
Our systematic review examining impact of conditional cash transfers 💵 on neglected tropical diseases 🪱🦠🦟is published! Well done Aaminah Ahmed for publishing your BSc dissertation in @LancetGH with colleagues from @PHPE_IC @ImperialSPH @cidacs_fiocruzhttps://t.co/zdRaufFuRY
— Thomas Hone (@tomhone) April 13, 2022
A nationwide observational analysis in Israel showed a fourth dose of the Pfizer vaccine may reduce the short-term risk of Covid-19–related outcomes.
14 Apr, 2022 | 08:51h | UTCEditorial: Covid-19 Boosters — Where from Here?
Related:
COVID-19: Joint statement from ECDC and EMA on the administration of a fourth dose of mRNA vaccines.
Perspective: The evidence on 4th doses of covid vaccines & the thorny question of age thresholds.
U.S. approves second Covid-19 booster for people 50 and older and immunocompromised individuals.
[Preprint] Fourth dose of COVID vaccine offers only slight boost against Omicron infection.
Covid-19: Fourth vaccine doses—who needs them and why?
[Not published yet] Study in Israel finds fourth COVID booster has limited efficacy.
Commentary on Twitter
In Israel, a fourth dose of BNT162b2 vaccine effective in reducing the short-term risk of Covid-19–related outcomes among those who had received a third dose at least 4 mos earlier. https://t.co/WtHiR9WbLW pic.twitter.com/yzWRLlgHUi
— NEJM (@NEJM) April 13, 2022
Study showed low rates of severe COVID-19 in children hospitalized with confirmed SARS-CoV-2 infection.
14 Apr, 2022 | 08:49h | UTCCommentary: Severe COVID-19 extremely rare among children – News Medical
Related:
COVID-19 disease severity in children infected with the Omicron variant.
Study identifies risk factors for severe CoviD-19 in children.
International study identifies predictors of severe outcomes in children with COVID-19.
Discharge preparation and readiness after birth: a scoping review of global policies, guidelines and literature.
14 Apr, 2022 | 08:07h | UTCRelated:
WHO recommendations on maternal and newborn care for a positive postnatal experience.
Putting positive experiences at the center of postnatal care.
Economic evaluation: cost-effectiveness of installing barriers at bridge and cliff sites for suicide prevention in Australia.
14 Apr, 2022 | 08:01h | UTCInvited Commentary: Rethinking Suicide Prevention as a Public Health Issue – JAMA Network Open
Commentary on Twitter
This economic evaluation found that barriers installed at multiple bridge sites – but not cliffs – in Australia were a cost-effective measure in reducing suicide rates at bridges. https://t.co/5D0MIzLZ1Y
— JAMA Network Open (@JAMANetworkOpen) April 5, 2022
Cohort Study: Mifepristone and misoprostol for undesired pregnancy of unknown location.
14 Apr, 2022 | 07:53h | UTCMifepristone and Misoprostol for Undesired Pregnancy of Unknown Location – Obstetrics & Gynecology
The burden of mental disorders, substance use disorders and self-harm among young people in Europe, 1990–2019: Findings from the Global Burden of Disease Study 2019.
13 Apr, 2022 | 11:03h | UTCInvited Commentary: The burden of young people’s mental health conditions in Europe: No cause for complacency – The Lancet Regional Health Europe
Related:
Commentary on Twitter
See our new @IHME_UW analysis from on the #burden of #mentaldisorders, substance use disorders & self-harm among young people in Europe. In 2019 there were 16,983 MDs cases/100.000. In last 30 yrs YLD for eating disorders & drug use disorders increased. https://t.co/hMbHDlPuur pic.twitter.com/Rt4Iq4tpAA
— Maciej Banach (@maciejbanach) April 2, 2022
(Article and images under a CC BY 4.0 license)
Perspective: The concept of classical herd immunity may not apply to COVID-19.
13 Apr, 2022 | 10:54h | UTCNews Release: NIH experts discuss controlling COVID-19 in commentary on herd immunity – NIH News Releases
Commentary on Twitter
Co-authored by Dr. Anthony Fauci and two other @NIAIDNews'ers
"We no longer need the elusive concept of 'herd immunity' as an aspirational goal: COVID-19 control is already within our grasp."https://t.co/kvYfpsXviB https://t.co/aaiGcb3qtL pic.twitter.com/6yrcsKbUGi
— Alexander Tin (@Alexander_Tin) March 31, 2022
Drug resistant TB – latest developments in epidemiology, diagnostics and management.
13 Apr, 2022 | 10:09h | UTCRelated:
Summary | WHO recommendations on the treatment of drug-resistant tuberculosis, 2020 update.
WHO Consolidated Guidelines on Drug-resistant Tuberculosis Treatment
Canadian Tuberculosis Standards – 8th Edition.
Guideline: Treatment of Drug-Resistant Tuberculosis
The Lancet Commission: Management of Multidrug-resistant and Incurable Tuberculosis
Regimens to Treat Multidrug-resistant Tuberculosis: Past, Present and Future Perspectives
New WHO online course: Monkeypox epidemiology, preparedness and response.
13 Apr, 2022 | 10:03h | UTCMonkeypox epidemiology, preparedness and response – OpenWHO
Commentary on Twitter
Monkeypox remains an under-recognized and underreported emerging disease. Good clinical management can limit disease severity or death.
Learn about prevention and control of #monkeypox in our 🆕 free online course on #OpenWHO:
👉 https://t.co/3MtOCbiVoI pic.twitter.com/o1NabpyEzD— World Health Organization (WHO) (@WHO) April 10, 2022
RCT: Single-dose HPV vaccination found effective among young African women.
12 Apr, 2022 | 10:08h | UTCEfficacy of Single-Dose Human Papillomavirus Vaccination among Young African Women – NEJM Evidence
News Releases:
Study boosts support for single-dose HPV vaccine regimen – University of Washington
Related:
Three-year follow-up of 2-dose versus 3-dose HPV vaccine
Commentary on Twitter (thread – click for more)
🚨 GAME CHANGER 🚨
One-dose Human Papillomavirus (#HPV) vaccine offers solid protection against cervical cancer: WHO https://t.co/3uWlZlCCVK pic.twitter.com/ZKDvpf2qog— World Health Organization (WHO) (@WHO) April 11, 2022
More data suggests the Omicron variant causes milder disease compared to the Delta variant.
12 Apr, 2022 | 09:49h | UTCRelated:
Perspective: Challenges in inferring intrinsic severity of the SARS-CoV-2 Omicron variant.
Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa.
[Preprint] SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters.
Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis.
11 Apr, 2022 | 01:58h | UTCInvited Commentary: How to interpret the total number of SARS-CoV-2 infections – The Lancet
Commentary on Twitter (thread – click for more)
Estimating #SARSCoV2 infections across the world is fraught with difficulties, hence the novel approach in the above study.@KayokoShioda & @B_Lopman discuss findings, interpretations, & implications. https://t.co/ua9arLXDOq
— The Lancet (@TheLancet) April 10, 2022